Ofer Haviv | executive |
Yoash Zohar | executive |
Yaron Eldad | executive |
Dan Jacob Gelvan | executive |
Amit Noam | executive |
Welcome to Evogene's Second Quarter Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded August 22, 2024.
Before we begin, I would like to caution that this presentation contains forward-looking statements relating to future events and Evogene's Ltd., the company may, from time to time, make other statements regarding our outlook or expectations for future financial or operating results and/or other matters regarding or affecting us that are considered forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995 and other securities laws, as amended. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Such forward-looking statements may be identified by the use of such words as believe, expect, anticipate, should, plan, estimated, intend and potential or words of similar meaning -- we are using forward-looking statements in this presentation when we discuss our value drivers: commercialization, efforts and timing, product development and launches estimated market sizes and milestones, pipeline as well as our capabilities and technology.